PortfoliosLab logoPortfoliosLab logo
Aclarion Inc (ACON)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US6551871022
IPO Date
Apr 22, 2022

Highlights

EPS (TTM)
-$12.59
Total Revenue (TTM)
$67.48K
Gross Profit (TTM)
-$5.29K
EBITDA (TTM)
-$7.12M
Year Range
$2.34 - $12.99
ROA (TTM)
-0.00%
ROE (TTM)
-0.00%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aclarion Inc

Often compared with ACON:
ACON vs. OPKACON vs. VCIG

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aclarion Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Aclarion Inc (ACON) has returned -28.91% so far this year and -69.72% over the past 12 months.


Aclarion Inc

1D
6.17%
1M
19.34%
YTD
-28.91%
6M
-56.40%
1Y
-69.72%
3Y*
-96.74%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Apr 22, 2022, ACON's average daily return is -0.58%, while the average monthly return is -14.57%.

Historically, 31% of months were positive and 69% were negative. The best month was May 2023 with a return of +55.7%, while the worst month was Mar 2025 at -88.1%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ACON closed higher 41% of trading days. The best single day was Mar 3, 2025 with a return of +126.9%, while the worst single day was Mar 6, 2025 at -77.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-28.04%-17.22%19.34%-28.91%
2025-85.28%-52.82%-88.06%-40.83%1.41%16.13%-7.64%3.13%4.64%3.47%-19.33%-26.52%-99.65%
2024-25.00%-83.40%-17.27%-8.92%-0.03%-4.70%10.21%-33.54%-12.42%0.38%-2.23%-20.00%-95.50%
202311.88%12.36%-10.85%-2.58%55.69%-30.01%-17.39%-10.53%-36.18%2.92%-19.40%-25.93%-65.52%
2022-23.90%-39.13%-27.50%6.19%14.43%-29.91%37.53%-28.00%-24.71%-78.68%

Benchmark Metrics

Aclarion Inc has an annualized alpha of -79.03%, beta of 0.88, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since April 25, 2022.

  • This stock participated in 273.92% of S&P 500 Index downside but only -168.43% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-79.03%
Beta
0.88
0.01
Upside Capture
-168.43%
Downside Capture
273.92%

Return for Risk

Risk / Return Rank

ACON ranks 10 for risk / return — in the bottom 10% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


ACON Risk / Return Rank: 1010
Overall Rank
ACON Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
ACON Sortino Ratio Rank: 1111
Sortino Ratio Rank
ACON Omega Ratio Rank: 1111
Omega Ratio Rank
ACON Calmar Ratio Rank: 77
Calmar Ratio Rank
ACON Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Aclarion Inc (ACON) and compare them to a chosen benchmark (S&P 500 Index).


ACONBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.71

0.90

-1.60

Sortino ratio

Return per unit of downside risk

-0.99

1.39

-2.37

Omega ratio

Gain probability vs. loss probability

0.87

1.21

-0.34

Calmar ratio

Return relative to maximum drawdown

-0.90

1.40

-2.30

Martin ratio

Return relative to average drawdown

-1.41

6.61

-8.02

Explore ACON risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Aclarion Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Aclarion Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aclarion Inc was 100.00%, occurring on Feb 5, 2026. The portfolio has not yet recovered.

The current Aclarion Inc drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Apr 25, 2022950Feb 5, 2026

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aclarion Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Aclarion Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ACON relative to other companies in the Health Information Services industry. Currently, ACON has a P/S ratio of 28.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items